M&A - ORASURE TECHNOLOGIES INC

Form Type: 8-K/A

Filing Date: 2025-05-09

Corporate Action: Acquisition

Type: Update

Accession Number: 000111646325000043

Filing Summary: OraSure Technologies, Inc. amends its previous Current Report on Form 8-K filed on December 26, 2024, to provide necessary financial information concerning its acquisition of Sherlock Biosciences, Inc. on December 19, 2024. This acquisition was executed under a Merger Agreement involving the Company, Project Watson Merger Sub, Inc., and Sherlock. The report includes pro forma financial statements that reflect the combined results of operations for both companies as if they had been merged at the start of the fiscal year 2024. However, these pro forma results are purely indicative and do not reflect actual operational outcomes for the period mentioned. The financial details of the acquisition, along with the unaudited pro forma statements, are presented as Exhibit 99.1 in the report.

Form Type: 8-K/A

Filing Date: 2025-03-07

Corporate Action: Acquisition

Type: Update

Accession Number: 000111646325000008

Filing Summary: OraSure Technologies, Inc. filed an amended Current Report on Form 8-K/A to supplement the original report from December 26, 2024, regarding its acquisition of Sherlock Biosciences, Inc. This acquisition occurred on December 19, 2024, as per a Merger Agreement between the two companies. The amendment provides additional financial information required by the SEC, detailing historical audited financial statements of Sherlock for the year ended December 31, 2023, and for the nine months ended September 30, 2024, as well as pro forma combined financial statements for the companies. The report also includes notes and independent auditor’s reports and presents this financial information for informational purposes, indicating that these figures do not necessarily reflect actual or projected operational outcomes of the combined entity.